Queen Saenz + Schutz PLLC (QS+S) represented firm client Iodine Software, LLC (Iodine) in its sale to Waystar for a total enterprise value of $1.25B. Iodine Software is a leader in AI-powered clinical intelligence. QS+S previously represented Iodine Software in connection with growth equity investments from Bain Capital Ventures and Silversmith Capital Partners in 2018, a growth equity investment from Advent International in 2021, and tuck-in acquisitions of Artifact Health, Inc. and ChartWise Medical Systems, Inc., both of which closed in 2021.
More information on the Iodine – Waystar transaction can be found here.